Centre Lists 34 Antimicrobials, Antivirals for Proposed Ban in Animals Under Drugs Act Farhat Nasim27 May 2025 7:39 PM ISTNew Delhi: The Central Government has issued a draft notification proposing the prohibition of import, manufacture, sale, and distribution of a total...
CDSCO Panel Clears Abbott's Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More Sites Dr. Divya Colin26 May 2025 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Abbott Healthcare...
Delhi HC Quashes IPO's Patent Rejection of Taiho Pharma's Cancer Drug, Orders Re-evaluation Farhat Nasim25 May 2025 4:00 PM ISTNew Delhi: In a ruling impacting pharmaceutical patent jurisprudence in India, the Delhi High Court has set aside the Indian Patent Office's (IPO)...
CDSCO Panel Approves Fabrazyme Label Update, Asks Sanofi to Submit EMA Nod Dr. Divya Colin25 May 2025 3:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Sanofi Healthcare...
Macleods Gets CDSCO Panel Go Ahead For Semaglutide Trials, Preclinical Data Sought Farhat Nasim24 May 2025 9:54 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Endocrinology and Metabolism, operating under the Central Drugs Standard Control Organisation...
Sanofi Gets CDSCO Panel Nod to Update Aldurazyme Prescribing Information Dr. Divya Colin24 May 2025 6:55 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Sanofi Healthcare...
CDSCO Flags Nandrolone Injection as 'Possibly Spurious' After Bihar Testing, Batch Under Investigation Dr. Divya Colin23 May 2025 9:50 PM ISTNew Delhi: In its latest drug alert for April 2025, the Central Drugs Standard Control Organization (CDSCO) has flagged a batch of Nandrolone...
CDSCO Panel Asks Regenix to Submit Additional Trial Data for Insulin Injection Approval Dr. Divya Colin23 May 2025 9:46 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has deferred its decision on the approval...
Zydus Told to Withdraw Unmarketed Strengths, Conduct Phase IV Trial for Approved Combinations Only Dr. Divya Colin23 May 2025 9:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus Healthcare Ltd. to...
Substandard Drugs Flagged Across Multiple States, Over 130 Batches Fail Quality Tests In April Farhat Nasim22 May 2025 6:45 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has flagged 136 batches of pharmaceutical products as Not of Standard Quality (NSQ)...
Zydus' Desidustat Gets Expert Panel Nod for Phase-III Trial in Cancer-Related Anemia Farhat Nasim21 May 2025 8:05 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Haematology has recommended for grant of permission to conduct a Phase-III clinical trial for...
CDSCO Panel Recommends Protocol Amendment for Novartis' Ianalumab Trial Farhat Nasim21 May 2025 8:03 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Haematology, functional under the Central Drugs Standard Control Organisation (CDSCO) has recommended...
